renumathyd(@renumathyd) 's Twitter Profileg
renumathyd

@renumathyd

Physician scientist @Stanford University| Passionate about liver cancer research| Gastroenterologist| Transplant hepatologist| Tweeting about #Science.

ID:16558786

linkhttps://med.stanford.edu/dhanasekaran-lab.html calendar_today02-10-2008 13:11:03

5,5K Tweets

3,3K Followers

3,1K Following

Stanford CME(@StanfordCME) 's Twitter Profile Photo

Only a few days left to register! Don't miss out on the 2024 Updates in & Conference.

4.17-4.20 | Sonoma, CA

Explore cutting-edge insights on esophageal disease, motility disorders, cancer screening & more!

Register: stanford.cloud-cme.com/course/courseo…

Only a few days left to register! Don't miss out on the 2024 Updates in #Gastroenterology & #Hepatology Conference. 4.17-4.20 | Sonoma, CA Explore cutting-edge insights on esophageal disease, motility disorders, cancer screening & more! #MedEd Register: stanford.cloud-cme.com/course/courseo…
account_circle
renumathyd(@renumathyd) 's Twitter Profile Photo

Such an honor to win the CGIT Shark Tank!!

Thanks American Gastroenterological Association (AGA) American Gastroenterological Association (AGA) Tech Summit for this opportunity to present the idea behind Arithmedics, the brain child of Vetri Venthan Elango.

Congrats to all the Shark Tank finalists and organizers!

account_circle
Stanford Div. of GI & Hepatology(@Stanford_GI) 's Twitter Profile Photo

Check out, and help us share our Spring Newsletter tinyurl.com/49uec5te!
We highlight exciting news:
1⃣Arrival of new faculty
2⃣The expansion of our hepatology program
3⃣A recent paper in Nature from the Torok lab
4⃣Celebrating multiple grants, awards and promotions

Check out, and help us share our Spring Newsletter tinyurl.com/49uec5te! We highlight exciting news: 1⃣Arrival of new faculty 2⃣The expansion of our hepatology program 3⃣A recent paper in Nature from the Torok lab 4⃣Celebrating multiple grants, awards and promotions #GITwitter
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

CheckMate-9DW Meets Primary Endpoint in 1st line HCC
👉Nivo/Ipi significantly improves OS
👉AtezoBev, DurvaTreme, CamRivo, now Nivo/Ipi... to be continued...
😅Could become an exciting year in HCC, more data in all stages to be reported
ESMO - Eur. Oncology ILCA EASLnews

CheckMate-9DW Meets Primary Endpoint in 1st line HCC 👉Nivo/Ipi significantly improves OS 👉AtezoBev, DurvaTreme, CamRivo, now Nivo/Ipi... to be continued... 😅Could become an exciting year in HCC, more data in all stages to be reported @myESMO @ILCAnews @EASLnews #livertwitter
account_circle
Patricia Garcia(@PGarciaMD) 's Twitter Profile Photo

Thank you Stanford Div. of GI & Hepatology and Stanford Primary Care and Population Health for being pioneers! Key takeaways:
✨ AI draft responses to patient messages reduce clinician burnout and cognitive load Stanford Health Care
📈 20% adoption in 5 weeks
📚 Real-world data key for strategic decisions
jamanetwork.com/journals/jaman…

account_circle
Fatty Liver Foundation(@LiverSaver) 's Twitter Profile Photo

Our Executive Director Henry E. Chang presented FLF's patient advocacy work at Stanford Div. of GI & Hepatology, thanks to Prof. Mindie Nguyen. We're expanding patient involvement from research design to results sharing. We appreciate this opportunity to share our initiatives & insights.

Our Executive Director @HenryEChang presented FLF's patient advocacy work at @Stanford_GI, thanks to Prof. Mindie Nguyen. We're expanding patient involvement from research design to results sharing. We appreciate this opportunity to share our initiatives & insights. #LiverTwitter
account_circle
George Ioannou(@gnioannou) 's Twitter Profile Photo

Nice study in CGH:
HCC screening in patients with cured HCV is cost-effective for those with HCC risk > 0.7% per year.
pubmed.ncbi.nlm.nih.gov/37302445/

What does this mean?
➡️Even some non-cirrhosis patients have HCC risk>0.7% and might benefit from screening hccrisk.com…

Nice study in @AGA_CGH: HCC screening in patients with cured HCV is cost-effective for those with HCC risk > 0.7% per year. pubmed.ncbi.nlm.nih.gov/37302445/ What does this mean? ➡️Even some non-cirrhosis patients have HCC risk>0.7% and might benefit from screening hccrisk.com…
account_circle
renumathyd(@renumathyd) 's Twitter Profile Photo

Congrats to my Anja, my mentor Dean Felsher, MD PhD and team! Proud to part of this work out in Nature Communications

🟢CRISPR-based screen to identify MYC synthetic genes in HCC.
🟢Targeting XPO1 in MYC-driven shows promise.
🟢Offers deep insights into MYC-driven cancer survival pathways

Congrats to my Anja, my mentor @LabDfelsher and team! Proud to part of this work out in @NatureComms 🟢CRISPR-based screen to identify MYC synthetic genes in HCC. 🟢Targeting XPO1 in MYC-driven #HCC shows promise. 🟢Offers deep insights into MYC-driven cancer survival pathways
account_circle
Stanford Div. of GI & Hepatology(@Stanford_GI) 's Twitter Profile Photo

Congratulations to our faculty Natalie J. Torok, her lab and her collaborators on this amazing study on liver cancer just published in nature!

The study has broad implications for risk of cancer in patients with diabetes.

Check it out here- rdcu.be/dxtNi

Congratulations to our faculty @TorokNatalie, her lab and her collaborators on this amazing study on liver cancer just published in @Nature! The study has broad implications for risk of cancer in patients with diabetes. Check it out here- rdcu.be/dxtNi
account_circle
renumathyd(@renumathyd) 's Twitter Profile Photo

Congrats Natalie J. Torok and team on this fantastic work in nature!
Thanks for including our lab!

Take a note

'This is clinically very relevant as increasing viscoelasticity could be a risk factor foretelling more invasive features of HCC in NASH/T2DM'

Congrats @TorokNatalie and team on this fantastic work in @Nature! Thanks for including our lab! Take a note #LiverTwitter #GITwitter 'This is clinically very relevant as increasing viscoelasticity could be a risk factor foretelling more invasive features of HCC in NASH/T2DM'
account_circle
Hepatoma Research(@HepatomaRes) 's Twitter Profile Photo

<Newly Published REVIEW>

👏Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy
👨‍⚕️Authors: Dr. Gahyun Gim and Dr. Nabeel Badri from Wilmot Cancer Institute
🔗oaepublish.com/articles/2394-…

<Newly Published REVIEW> #icca #BTC #targetedtherapy #immunotherapy #meded #livertwitter 👏Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy 👨‍⚕️Authors: Dr. Gahyun Gim and Dr. Nabeel Badri from @WilmotCancer 🔗oaepublish.com/articles/2394-…
account_circle
Stanford Div. of GI & Hepatology(@Stanford_GI) 's Twitter Profile Photo

Looking back on a year brimming with clinical excellence, research accomplishments, great teamwork and moments of pure fun! Here's a video of all the laughter, discoveries, and breakthroughs we've shared!

Wishing everyone a joyful holiday season!

youtu.be/shZ80HWQ578?fe…

Looking back on a year brimming with clinical excellence, research accomplishments, great teamwork and moments of pure fun! Here's a video of all the laughter, discoveries, and breakthroughs we've shared! Wishing everyone a joyful holiday season! youtu.be/shZ80HWQ578?fe…
account_circle
Stanford Div. of GI & Hepatology(@Stanford_GI) 's Twitter Profile Photo

This article introduces our Division Chief W Ray Kim, the 2024 AASLD President, we are proud of his journey and look forward to his leadership at AASLD!

Introducing W. Ray Kim, MD, our 2024 AASLD president : Hepatology journals.lww.com/hep/abstract/2…

This article introduces our Division Chief @WRayKimMD, the 2024 @AASLDtweets President, we are proud of his journey and look forward to his leadership at AASLD! Introducing W. Ray Kim, MD, our 2024 AASLD president : Hepatology journals.lww.com/hep/abstract/2…
account_circle
renumathyd(@renumathyd) 's Twitter Profile Photo

Check out our review in @Jhepatology!

Paul Monga and I discuss 'Battle of the Biopsies: Role of tissue and liquid biopsy in HCC'-
🔴 Challenges and potential of both
🔴 How they will jointly reshape

Thanks @Blehrich and Jo Zhang for the hard work!

sciencedirect.com/science/articl…

Check out our review in @Jhepatology! @DrPMonga and I discuss 'Battle of the Biopsies: Role of tissue and liquid biopsy in HCC'- 🔴 Challenges and potential of both 🔴 How they will jointly reshape #HCC Thanks @Blehrich and Jo Zhang for the hard work! sciencedirect.com/science/articl…
account_circle